Monday, April 12, 2021

Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes

xloma.fota13 shared this article with you from Inoreader

13046.jpg

Innovative therapies to target tumor-associated neutrophils (PMN) are of clinical interest, since these cells are centrally involved in cancer inflammation and tumor progression. Resolvin D1 (RvD1) is a lipid ...
View on the web
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Collaboration request

Hi there How would you like to earn a 35% commission for each sale for life by selling SEO services Every website owner requires the ...